This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Senti Biosciences, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kathryn Armstrong Loving: Innovator in Chimeric Receptor Technology
Introduction
Kathryn Armstrong Loving is a prominent inventor based in Berkeley, CA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric receptors for cancer treatment. Her innovative work focuses on acute myeloid leukemia, a challenging area in oncology.
Latest Patents
Kathryn holds 1 patent for her invention titled "Chimeric receptors and methods of use thereof." This patent provides critical insights into acute myeloid leukemia antigen targets for chimeric receptors and outlines methods for utilizing these advancements in therapeutic applications.
Career Highlights
Currently, Kathryn is associated with Senti Biosciences, Inc., where she continues to push the boundaries of cancer research and treatment. Her work is instrumental in developing novel therapies that aim to improve patient outcomes in oncology.
Collaborations
Throughout her career, Kathryn has collaborated with notable professionals in her field, including Brian Scott Garrison and Jennifer Chien. These partnerships have fostered a collaborative environment that enhances innovation and research in chimeric receptor technology.
Conclusion
Kathryn Armstrong Loving is a trailblazer in the field of chimeric receptor technology, with her patent and ongoing work at Senti Biosciences, Inc. showcasing her commitment to advancing cancer treatment. Her contributions are paving the way for future innovations in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile